High Court Urged To Deny Review Of Nixed DNA-Test Patent
The U.S. Supreme Court should deny Sequenom Inc.'s bid for a review of its fetal DNA test patent because the Federal Circuit correctly applied the high court's Alice, Mayo and Myriad...To view the full article, register now.
Already a subscriber? Click here to view full article